|
|
Vioxx gained widespread acceptance among physicians treating patients with arthritis and other conditions causing chronic or acute pain. Worldwide, over 80 million people were prescribed Vioxx at some time.
Rofecoxib was approved as safe and effective by the Food and Drug Administration (FDA) on May 20, 1999, and was subsequently marketed under the brand name Vioxx, Ceoxx and Ceeoxx.
On September 30, 2004, Merck voluntarily withdrew Vioxx from the market because of concerns about increased risk of heart attack and stroke associated with long-term, high-dosage use, which was also when the need for a good attorney in the field became needed. Vioxx was one of the most widely used drugs ever to be withdrawn from the market. In the year before withdrawal, Merck had sales revenue of US$2.5 billion from Vioxx. That also made the need for an attorney looking after the public 's interest more viable, with so much money involved.
Vioxx was available on prescription as tablets and as an oral suspension.
|
|
| |
